About Us

Board of Directors

Our Board of Directors is composed of an independent chair; a regional distribution of jurisdictional federal, provincial, and territorial representatives; and a number of non-jurisdictional representatives from health systems, academia, and the general public. Directors are elected by the Members of the Corporation, who are the Deputy Ministers of Health for participating federal, provincial, and territorial governments.

The Board has overall responsibility for administering the affairs of the Corporation and providing the strategic direction to guide our success as the Canadian "go-to" provider of evidence and advice on the use of drugs and other health technologies.

At this time, Canada’s Drug Agency is seeking nominations for the position of Chair of its Board of Directors.

This position offers a unique opportunity to help shape how evidence is used to power decisions about drugs and health technologies and improve the quality, value, and sustainability of our health systems.

Qualified individuals are invited to submit a nomination via the submission portal on the Odgers Berndtson website. Odgers Berndtson is supporting this recruitment process for Canada’s Drug Agency.

Chair of the Board

David Agnew

Federal

Michelle Boudreau
Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada

Jurisdictional

Western Provinces

Robert Shaffer

Robert Shaffer
Assistant Deputy Minister, Manitoba Health

Natalie McMurtry
Assistant Deputy Minister, Pharmaceutical and Supplementary Benefits, Alberta Health

Atlantic Provinces

John McGrath

John McGrath
Deputy Minister, Department of Health and Community Services, Government of Newfoundland & Labrador

Éric Levesque
Associate Deputy Minister, Francophone Affairs, Pharmaceutical, Physician and Community Services (Division) Health, Province of New Brunswick